Cargando…
晚期肺腺癌EGFR-TKIs对后续培美曲赛化疗的影响
BACKGROUND AND OBJECTIVE: Pemetrexed and epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) were used in patients with EGFR mutation to determine their effects. This study analyzed the influence of EGFR-TKIs on pemetrexed by observing the clinical efficacy and toxicity of peme...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000128/ https://www.ncbi.nlm.nih.gov/pubmed/22613336 http://dx.doi.org/10.3779/j.issn.1009-3419.2012.05.08 |
Ejemplares similares
-
ALK基因状态与晚期肺腺癌患者一线培美曲塞化疗疗效的关系
Publicado: (2017) -
培美曲赛单药与培美曲赛联合奥沙利铂用于Ⅳ期肺腺癌挽救性治疗的比较
Publicado: (2011) -
HER2基因状态与晚期肺腺癌患者一线培美曲塞联合铂类化疗疗效的关系
Publicado: (2019) -
贝伐珠单抗联合培美曲塞加卡铂新辅助化疗方案对Ⅲa期肺腺癌手术安全性的影响
Publicado: (2015) -
培美曲塞治疗全身化疗和吉非替尼治疗失败的肺腺癌32例临床观察
Publicado: (2010)